tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

MLLCF Stock Latest News

Molecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
RatingsMolecular Partners: Strong Cash Runway and Pipeline Catalysts Support DCF‑Backed Buy Rating and $13 Target
7d ago
MOLN
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
PremiumRatings
Undervalued Radioligand Leader: Molecular Partners’ Differentiated RadioDARPin Platform Underpins Buy Rating
7d ago
MOLN
Buy Recommendation on Molecular Partners: Advancing Radio-DARPin Platform, Strategic Isotope Collaboration, and Cash Runway Through 2028 Underpin Attractive Risk‑Reward
PremiumRatings
Buy Recommendation on Molecular Partners: Advancing Radio-DARPin Platform, Strategic Isotope Collaboration, and Cash Runway Through 2028 Underpin Attractive Risk‑Reward
9d ago
MOLN
Buy Rating on Molecular Partners: Expanding Radiopharmaceutical Platform, Isotope Partnership, and Flexible DARPin Strategy Support Favorable Risk-Reward
PremiumRatings
Buy Rating on Molecular Partners: Expanding Radiopharmaceutical Platform, Isotope Partnership, and Flexible DARPin Strategy Support Favorable Risk-Reward
24d ago
MOLN
Molecular Partners enters Radio-DARPin therapeutics pact with Eckert & Ziegler
PremiumThe Fly
Molecular Partners enters Radio-DARPin therapeutics pact with Eckert & Ziegler
25d ago
MOLN
Molecular Partners presents first imaging, dosimetry data of MP0712
PremiumThe FlyMolecular Partners presents first imaging, dosimetry data of MP0712
2M ago
MOLN
Molecular Partners initiated with a Buy at H.C. Wainwright
Premium
The Fly
Molecular Partners initiated with a Buy at H.C. Wainwright
2M ago
MOLN
Molecular Partners provided update on latest progress, 2026 milestones
Premium
The Fly
Molecular Partners provided update on latest progress, 2026 milestones
2M ago
MOLN
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
PremiumCompany Announcements
Molecular Partners Advances DLL3 Radioligand Program With New Phase 1/2a Cancer Trial
2M ago
MLLCF
Molecular Partners forms Scientific Advisory Board
PremiumThe Fly
Molecular Partners forms Scientific Advisory Board
3M ago
MOLN
Promising Pipeline and Strategic Focus Drive Buy Rating for Molecular Partners
PremiumRatings
Promising Pipeline and Strategic Focus Drive Buy Rating for Molecular Partners
3M ago
MOLN
Molecular Partners price target lowered to CHF 3 from CHF 3.50 at JPMorgan
PremiumThe Fly
Molecular Partners price target lowered to CHF 3 from CHF 3.50 at JPMorgan
3M ago
MOLN
Molecular Partners price target lowered to $3.75 from $4 at JPMorgan
PremiumThe FlyMolecular Partners price target lowered to $3.75 from $4 at JPMorgan
3M ago
MOLN
Molecular Partners presents updated data from Phase 1/2a trial of MP0533
Premium
The Fly
Molecular Partners presents updated data from Phase 1/2a trial of MP0533
4M ago
MOLN
Buy Rating for Molecular Partners: Innovative Pipeline and Promising SCLC Advancements
Premium
Ratings
Buy Rating for Molecular Partners: Innovative Pipeline and Promising SCLC Advancements
4M ago
MOLN
Molecular Partners presents new MP0712 data
PremiumThe Fly
Molecular Partners presents new MP0712 data
4M ago
MOLN
Molecular Partners: Promising Pipeline and Strategic Partnerships Justify Buy Rating
PremiumRatings
Molecular Partners: Promising Pipeline and Strategic Partnerships Justify Buy Rating
5M ago
MOLN
Molecular Partners price target lowered to $4 from $4.50 at JPMorgan
PremiumThe Fly
Molecular Partners price target lowered to $4 from $4.50 at JPMorgan
7M ago
MOLN
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
PremiumRatings
Molecular Partners: Promising Pipeline and Financial Stability Justify Buy Rating Despite IND Delay
7M ago
MOLN
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
PremiumRatingsPromising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
7M ago
MOLN
Molecular Partners Reports H1 2025 Progress and Financial Stability
Premium
Company Announcements
Molecular Partners Reports H1 2025 Progress and Financial Stability
7M ago
Molecular Partners’ Promising Pipeline and Strategic Advancements Justify Buy Rating
Premium
Ratings
Molecular Partners’ Promising Pipeline and Strategic Advancements Justify Buy Rating
7M ago
MOLN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >